Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last CNY64.81 CNY
Change Today -4.28 / -6.19%
Volume 9.9M
002424 On Other Exchanges
As of 3:00 AM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

guizhou bailing group phar-a (002424) Snapshot

Previous Close
Day High
Day Low
52 Week High
05/28/15 - CNY112.97
52 Week Low
08/4/14 - CNY28.52
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for GUIZHOU BAILING GROUP PHAR-A (002424)

Related News

No related news articles were found.

guizhou bailing group phar-a (002424) Related Businessweek News

No Related Businessweek News Found

guizhou bailing group phar-a (002424) Details

Guizhou Bailing Group Pharmaceutical Co., Ltd. manufactures and distributes medicines. The company manufactures Miao ethno medicines; and cultivates and sells Chinese herbal medicine materials. Its medicine products primarily include syrups, and capsules used in the treatment of cardiovascular and cerebrovascular diseases, cough, and cold. The company is also involved in the production and sale of purified water. Guizhou Bailing Group Pharmaceutical Co., Ltd. is based in Anshun, China.

guizhou bailing group phar-a (002424) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

guizhou bailing group phar-a (002424) Key Developments

Guizhou Bailing Group Pharmaceutical Co., Ltd. Announces Expansion for Building Soft Capsule Production

Guizhou Bailing Group Pharmaceutical Co. Ltd. declared to use financing of CNY 132 million for building soft capsule production line expansion project to enlarge domestic market share, satisfying production demand for soft capsules, expanding production and optimizing product ranges through technology update, strengthening competitiveness and lifting up prime operating revenue and profit.

Guizhou Bailing Group Pharmaceutical Co.,Ltd Announces Cash Dividend for 2014, Payable on June 23, 2015

Guizhou Bailing Group Pharmaceutical Co.,Ltd announced 2014 final distribution plan to be implemented (A shares) as cash dividend (tax included) of CNY 2.00000000 per ten shares. Record date is June 19, 2015 and Ex-date is June 23, 2015. Payable on June 23, 2015.

Guizhou Bailing Group Pharmaceutical Co., Ltd. and Tencent Holdings Team Up for Online Medical Service of Chronic Diseases

Guizhou Bailing Group Pharmaceutical Co. Ltd. and Tencent Holdings have reached cooperation for online medical service of chronic diseases, making full use of rich user data, mature cloud computing capacity, strong social networking platform and media platform of Tencent Holdings to bolster up application, information management and medical service of chronic diseases. Both sides will team up for long term, with Guizhou Bailing Group taking charge of developing, making and testing drugs for chronic diseases, offering medical instruments and distance medical consultancy, management and diagnosis service.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
002424:CH CNY64.81 CNY -4.28

002424 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 002424.
View Industry Companies

Industry Analysis


Industry Average

Valuation 002424 Industry Range
Price/Earnings 92.4x
Price/Sales 19.1x
Price/Book 12.7x
Price/Cash Flow 92.6x
TEV/Sales 18.1x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GUIZHOU BAILING GROUP PHAR-A, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at